These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12560937)

  • 21. Antiemetic agents.
    Wilkes G
    Oncology (Williston Park); 2007 Jul; 21(8 Suppl):48. PubMed ID: 17844897
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.
    Campos D; Pereira JR; Reinhardt RR; Carracedo C; Poli S; Vogel C; Martinez-Cedillo J; Erazo A; Wittreich J; Eriksson LO; Carides AD; Gertz BJ
    J Clin Oncol; 2001 Mar; 19(6):1759-67. PubMed ID: 11251007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
    Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
    Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
    Hsu ES
    Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day highly or moderately emetogenic chemotherapy: role of transdermal granisetron.
    Coluzzi F; Mattia C
    Future Oncol; 2016 Aug; 12(16):1865-76. PubMed ID: 27184113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
    Tan M; Xu R; Seth R
    Curr Med Res Opin; 2004 Jun; 20(6):879-82. PubMed ID: 15200746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
    Nukariya N; Nakarai I; Kobayashi H; Koizumi W; Komatsu H; Uchiyama T; Yamaguchi T; Taira O; Minato K; Futatsugi K
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1821-9. PubMed ID: 7574816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. About the antiemetic effectivity of granisetron in chemotherapy-induced acute emesis: a comparison of results with intravenous and oral dosing.
    Lehoczky O
    Neoplasma; 1999; 46(2):73-9. PubMed ID: 10466429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of antiemetic efficacy of granisetron as premedication versus combination therapy of granisetron].
    Ikeda H; Koshiba R
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1947-53. PubMed ID: 9797818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimising antiemetic therapy: what are the problems and how can they be overcome?
    Aapro M
    Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granisetron: the second serotonin-receptor antagonist.
    Adams VR; Valley AW
    Ann Pharmacother; 1995 Dec; 29(12):1240-51. PubMed ID: 8672830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granisetron and ondansetron for chemotherapy-related nausea and vomiting.
    Zeidman A; Ben Dayan D; Ben Zion T; Kaufman O; Cohen AM; Mittelman M
    Haematologia (Budap); 1998; 29(1):25-31. PubMed ID: 9704254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer.
    Fujiwara S; Terai Y; Tsunetoh S; Sasaki H; Kanemura M; Ohmichi M
    J Gynecol Oncol; 2015 Oct; 26(4):311-9. PubMed ID: 26197776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiemetic effect of granisetron in lower hemibody radiotherapy.
    Logue JP; Magee B; Hunter RD; Murdoch RD
    Clin Oncol (R Coll Radiol); 1991 Sep; 3(5):247-9. PubMed ID: 1657114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT3 receptor antagonists for prevention of late acute-onset emesis.
    Constenla M
    Ann Pharmacother; 2004 Oct; 38(10):1683-91. PubMed ID: 15316106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis.
    Martoni A; Piana E; Strocchi E; Angelelli B; Guaraldi M; Zamagni C; Camaggi CM; Pannuti F
    Anticancer Res; 1998; 18(4B):2799-803. PubMed ID: 9713464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Cunningham RS
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.